Fluviral™
Sponsors
GlaxoSmithKline
Conditions
Influenza
Phase 3
Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults
CompletedNCT01389479
Start: 2005-01-31End: 2005-05-31Updated: 2017-06-08
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older
CompletedNCT01878825
Start: 2013-07-18End: 2013-08-09Updated: 2018-09-07